We are live on ! Find out more
PHAT icon

Phathom Pharmaceuticals
PHAT

94 hedge funds and large institutions have $334M invested in Phathom Pharmaceuticals in 2022 Q3 according to their latest regulatory filings, with 19 funds opening new positions, 34 increasing their positions, 23 reducing their positions, and 18 closing their positions.

New
Increased
Maintained
Reduced
Closed

63,800% more call options, than puts

Call options by funds: $1.92M | Put options by funds: $3K

48% more repeat investments, than reductions

Existing positions increased: 34 | Existing positions reduced: 23

41% more capital invested

Capital invested by funds: $237M → $334M (+$97.6M)

7.06% more ownership

Funds ownership: 69.98% → 77.04% (+7.1%)

6% more first-time investments, than exits

New positions opened: 19 | Existing positions closed: 18

0% more funds holding

Funds holding: 94 → 94 (0)

25% less funds holding in top 10

Funds holding in top 10: 4 → 3 (-1)

Holders
94
Holders Change
–
Holders Change %
0%
% of All Funds
1.62%
Holding in Top 10
3
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-25%
% of All Funds
0.05%
New
19
Increased
34
Reduced
23
Closed
18
Calls
$1.92M
Puts
$3K
Net Calls
+$1.91M
Net Calls Change
+$450K

Top Buyers

1
FLSM
Frazier Life Sciences Management
California
+$24.6M
2
DM
Deerfield Management
New York
+$23M
3
6CM
683 Capital Management
New York
+$2.13M
4
CS
Candriam SCA
Luxembourg
+$1.07M
5
GKIM
GW&K Investment Management
Massachusetts
+$950K

Top Sellers

1
Janus Henderson Group
Janus Henderson Group
United Kingdom
-$9.22M
2
Vanguard Group
Vanguard Group
Pennsylvania
-$8.72M
3
Mirae Asset Global Investments
Mirae Asset Global Investments
South Korea
-$6.7M
4
EAM
Eventide Asset Management
Massachusetts
-$2.84M
5
WSL
Western Standard LLC
California
-$920K
Name Holding Trade Value Shares
Change 		Change in
Stake
Morgan Stanley
26
Morgan Stanley
New York
$1.02M -$157K -16,432 -15%
PMAM
27
Penn Mutual Asset Management
Pennsylvania
$963K – – –
State of Wisconsin Investment Board
28
State of Wisconsin Investment Board
Wisconsin
$961K -$11K -1,152 -1%
Bank of New York Mellon
29
Bank of New York Mellon
New York
$814K +$87.3K +9,163 +14%
Bank of America
30
Bank of America
North Carolina
$784K -$198K -20,796 -23%
SEI Investments
31
SEI Investments
Pennsylvania
$660K -$39.2K -4,110 -6%
Goldman Sachs
32
Goldman Sachs
New York
$635K +$47.4K +4,970 +9%
HWAM
33
Hennion & Walsh Asset Management
New Jersey
$606K -$17.5K -1,833 -3%
HF
34
HRT Financial
New York
$585K +$503K +52,801 New
Millennium Management
35
Millennium Management
New York
$558K +$480K +50,396 New
CWM
36
Curi Wealth Management
North Carolina
$499K +$429K +45,000 New
Swiss National Bank
37
Swiss National Bank
Switzerland
$460K – – –
Squarepoint
38
Squarepoint
New York
$381K +$177K +18,529 +117%
Jane Street
39
Jane Street
New York
$350K +$301K +31,569 New
OAM
40
Occidental Asset Management
California
$329K – – –
RhumbLine Advisers
41
RhumbLine Advisers
Massachusetts
$321K +$21.7K +2,278 +9%
California State Teachers Retirement System (CalSTRS)
42
California State Teachers Retirement System (CalSTRS)
California
$268K -$6.76K -710 -3%
Two Sigma Advisers
43
Two Sigma Advisers
New York
$267K -$83.8K -8,800 -27%
Susquehanna International Group
44
Susquehanna International Group
Pennsylvania
$265K +$228K +23,899 New
IWA
45
Inspirion Wealth Advisors
Illinois
$258K – – –
Balyasny Asset Management
46
Balyasny Asset Management
Illinois
$205K +$177K +18,532 New
CSS
47
Cubist Systematic Strategies
Connecticut
$203K +$174K +18,294 New
VEA
48
Virtus ETF Advisers
New York
$187K +$1.15K +121 +0.7%
State Board of Administration of Florida Retirement System
49
State Board of Administration of Florida Retirement System
Florida
$178K -$95 -10 -0.1%
AllianceBernstein
50
AllianceBernstein
Tennessee
$175K +$11.4K +1,200 +8%
1
2
3 4 5

PHAT Hedge Fund Activity: Q3 2022 in Review

94 of the 5,805 institutional investors tracked by Wall St. Rank reported a position in Phathom Pharmaceuticals (PHAT) for Q3 2022, worth a combined $334M — up 41% from $237M a quarter earlier.

Buyers outnumbered sellers: 19 funds opened new PHAT positions and 18 closed out — a net gain of 1 holder — while 34 added to existing stakes and 23 trimmed.

The largest buyer was Frazier Life Sciences Management, adding an estimated $24.6M. The largest seller was Janus Henderson Group, exiting entirely with an estimated $9.22M sold.

  • 94 institutional investors held Phathom Pharmaceuticals (PHAT) as of Q3 2022, unchanged from Q2 2022.
  • Funds reported $334M of Phathom Pharmaceuticals stock for Q3 2022, up 41% quarter-over-quarter.
  • 19 funds opened new Phathom Pharmaceuticals positions in Q3 2022 and 18 closed out, a net change of +1 holder.
  • The largest Phathom Pharmaceuticals buyer in Q3 2022 was Frazier Life Sciences Management, an estimated $24.6M added.
  • The largest Phathom Pharmaceuticals seller in Q3 2022 was Janus Henderson Group, an estimated $9.22M sold.

Based on aggregated 13F filings for Q3 2022.